Patient engagement in health technology assessment (HTA) and the regulatory process: what about rheumatology?

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{03c351f8430b470390f92ae72c08e42e,

title = "Patient engagement in health technology assessment (HTA) and the regulatory process: what about rheumatology?",

author = "\{de Wit\}, Maarten and Francis Guillemin and Sabine Grimm and Annelies Boonen and Bruno Fautrel and Manuela Joore",

year = "2020",

month = nov,

doi = "10.1136/rmdopen-2020-001286",

language = "English",

volume = "6",

journal = "RMD Open",

issn = "2056-5933",

publisher = "BMJ Publishing Group",

number = "3",

}

TY - JOUR

T1 - Patient engagement in health technology assessment (HTA) and the regulatory process

T2 - what about rheumatology?

AU - de Wit, Maarten

AU - Guillemin, Francis

AU - Grimm, Sabine

AU - Boonen, Annelies

AU - Fautrel, Bruno

AU - Joore, Manuela

PY - 2020/11

Y1 - 2020/11

U2 - 10.1136/rmdopen-2020-001286

DO - 10.1136/rmdopen-2020-001286

M3 - Article

C2 - 33148783

SN - 2056-5933

VL - 6

JO - RMD Open

JF - RMD Open

IS - 3

ER -